Objectives: The aim of the study was to test whether or not the use of a polyethylene glycol (PEG) hydrogel with or without the addition of an arginylglycylaspartic acid (RGD) sequence applied as a matrix in combination with hydroxyapatite/tricalciumphosphate (HA/TCP) results in similar periimplant bone regeneration as traditional guided bone regeneration procedures.
Introduction
Polyethylene glycol (PEG) hydrogel was introduced in dentistry as a biodegradable membrane for guided bone regeneration (GBR) procedures (Jung et al. 2009a,b; Schwarz et al. 2010; Thoma et al. 2012; Zambon et al. 2012) . A number of preclinical and clinical trials evaluated a degradable, form-stable PEG formulation with a long-term barrier function (Jung et al. 2006 ). This PEG hydrogel demonstrated to be clinically effective in regenerating bone around dental implants similar to a native collagen membrane up to 5 years .
However, this dense PEG formulation showed a significantly higher exposure rate compared to sites grafted with a collagen membrane (Vierra et al. 2016) . To further enhance the clinical handling and to reduce the incidence of postoperative complications, numerous attempts were made to improve cell adhesion of the PEG hydrogel by testing less dense PEG formulations, associated with a reduction in the degradation time (Halstenberg et al. 2002; Park et al. 2004 Park et al. , 2005 Dahlin et al. 2014) . Beside the variation of the density, the properties of PEG can be changed by the addition of molecules. Results from a preclinical trial in the rabbit skull demonstrated that the modification of the PEG network with an arginylglycylaspartic acid (RGD) sequence affected soft tissue attachment, bone regeneration, and the host's immunologic reaction (Thoma et al. 2011) . The dense network PEG demonstrated its ability to serve as a barrier membrane with the option of enhancing the soft tissue integration by adding a RGD sequence. It was also speculated that the looser network PEG hydrogel might have the potential to serve as a carrier or stand-alone material for localized bone regeneration and that the addition of RGD might further improve bone formation. In this context, PEG shall be used as a matrix mixed with a bone substitute material, not as a covering membrane (Hanseler et al. 2012; Jung et al. 2014) . This is supported by a recent preclinical study , demonstrating that the addition of a loose network polyethylene glycol hydrogel to a synthetic bone substitute material increased new bone formation compared to the bone substitute material alone at 21 days. It was thereby concluded that the PEG hydrogel matrix might represent an interesting candidate to serve as a matrix for localized bone regeneration with or without the addition of a bone substitute material. It was also concluded that further studies are needed to confirm these results to apply the combination of a loose network PEG hydrogel and a bone substitute material in more challenging defect models and for guided bone regeneration procedures at implant sites.
The aim of this study was therefore to test whether or not the use of a PEG hydrogel applied as a matrix in combination with hydroxyapatite/tricalcium phosphate (HA/ TCP) results in similar peri-implant bone regeneration as a control treatment using a membrane covering the same bone substitute.
Materials and methods

Experimental animals
The article was written in accordance with the guidelines of the ARRIVE (Animal research: Reporting of in vivo experiments) protocol (Kilkenny et al. 2010) . The protocol was approved by the local ethical committee prior to the beginning of the experiment, and the study was performed at the animal laboratory of Yonsei University, Seoul, South Korea.
Animals
A total of 12 male beagle dogs with a fully developed permanent dentition and healthy periodontal tissues were included in this study. Four weeks prior to the experiment and during the entire study, the dogs were fed with a soft-food diet and water ad libitum. At the beginning, the animals had a mean age of 18 months and a mean weight of 15 kg. All experiments were performed at the animal laboratory accredited by Association for Assessment and Accreditation of Laboratory Animal (AAALAC) international, after ethical approval of the institutional Animal Care and Use Committee regarding animal selection, management, and surgery control.
Guided bone regeneration materials
The bone substitute material used in this study was a synthetic material consisting of HA/TCP granules (Straumann Bone Ceramic 500-1000 lm; Straumann, Basel, Switzerland). The experimental PEG hydrogel had a biodegradation of 4 weeks and was applied as a matrix for the bone substitute and RGD. No further membrane coverage was performed in these groups.
Surgical procedures
The surgical procedures were described in detail in a previous publication . In brief, all P4 and M1 were extracted in the maxilla. Following a healing period of 2 months, implant placement and periimplant bone regeneration were performed. For that purpose, dogs were pre-medicated with medetomidine (0.005 mg/kg, intramuscularly) and morphine (0.5 mg/kg intramuscularly). Subsequently, general anesthesia was induced by injection of propofol (2 mg/ kg intravenously). Isoflurane (1.5-2%) and O 2 (100%) were used as inhalation anesthetics. The animals were monitored routinely, and further analgesia was given if necessary within the first days following all surgical procedures. Following a mid-crestal incision between the M2 and the canine and two vertical releasing incisions (mesial and distal to the edentulous area), the buccal and lingual alveolar bone plates were exposed. After removing all granulation tissue, the edentulous ridges were slightly flattened to obtain a bucco-oral width of at least 7 mm. Two standardized box-shaped defects were created with a mesio-distal width of 4 mm, buccooral depth of 2 mm, and a vertical height of 4 mm using a straight fissure carbide bur. The defect sites were rinsed with sterile saline to completely remove any residual debris, and the dimensions of the defect were verified using a periodontal probe. Subsequently, 8-mm-long and 4.1-mm-diameter dental implants (Straumann Bone Level; Straumann) were placed in the center of the defects with a final peri-implant dehiscence of 4 mm (Fig. 1a) . The buccal cortical bone plates were perforated, and the following four treatment modalities randomly applied to the periimplant defects: In groups PEG and PEG-RGD, the bone substitute material was mixed with the liquid PEG hydrogel and applied to the periimplant defects (Fig. 1b) . In group CM, the bone substitute material was applied to the defect and then covered with the collagen membrane, thereby extending 1 mm beyond the augmented margins (Fig. 1c) . No further treatment was applied in empty control sites (Fig. 1c) . Following periosteal-releasing incisions, the mucoperiosteal flaps were coronally advanced and primary wound closure was accomplished by placing horizontal mattress sutures and interrupted sutures (Monosyn â 4.0 Glyconate Monofilament; B.
Braun Tuttlingen, Germany). Sutures were removed 14 days after surgery (Fig. 1d) . After a healing period of 8 weeks (n = 6) and 16 weeks (n = 6), the animals were painlessly sacrificed with an overdose of sodium pentobarbital 3%. All surgical sites were macroscopically inspected, and any incidences were recorded. The maxillae were block-resected including the surrounding soft tissues.
Micro-CT analyses
A micro-CT (SkyScan 1072; SkyScan, Aartselaar, Belgium) was taken following block resection at a resolution of 35 lm (100 kV, 100 lA). The obtained data set was processed, and the region of interest reconstructed with three-dimensional (3D) software (OnDemand3D â ; Cybermed, Seoul, Korea). The first bone-to-implant contact (fBIC) was measured on the lingual (fBIC_lCT) and buccal (fBIC_bCT) side of the implants to the nearest 0.1 mm. Bucco-oral horizontal thickness (HT in mm) of the mineralized tissue was analyzed at the level of the implant shoulder (HT_0), at 2 mm (HT_2) and 4 mm (HT_4) below the implant shoulder (Fig. 2) .
Histological preparation
The specimens were fixed in 10% formalin for 2 weeks. After fixation, samples were grossly bisected at the center of the defect in a mesio-distal direction using the EXAKT cutting system (EXAKT â Apparatebau, Norderstedt, Germany). Specimens were dehydrated using an ascending series of alcohol and embedded in methacrylate-based resin to permit sectioning of bone with the bone graft and dentin in situ. Subsequently, the embedded blocks were polymerized and then fixed to the vacuum head of the EXAKT macrocutter. Sections were prepared with a thickness of approximately 100 lm. These sections were then ground and polished on the EXAKT microgrinder to a thickness of 15 lm, mounted on microscope slides and stained with hematoxylin-eosin.
Histomorphometric analysis
One experienced investigator who was not aware of the specific experimental conditions performed all analyses. Images were captured with a digital camera (Leica Microsystems digital camera Type DFC 450; Wetzlar, Germany) connected to a light microscope (Leica Microsystems microscope Type DM6000 B). For histomorphometrical analysis, digital images were evaluated using an image
Micro-CT at 8 weeks for polyethylene glycol PEG (a), PEG hydrogel supplemented with RGD (PEG-RGD) (b), collagen membrane (CM) (c), empty control (d). PEG, synthetic particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD, synthetic particulated bone substitute material mixed a synthetic PEG hydrogel supplemented with RGD; CM, synthetic particulated bone substitute material covered with a non-cross-linked native collagen membrane. Micro-CT measurements of buccal and lingual first bone-to-implant contact (fBIC_CT) are shown in blue. Horizontal thickness measurements (red) at the buccal implant shoulder (HT_0) and at 2 mm (HT_2), respectively, 4 mm (HT_4) below the implant shoulder. Green measurements determine the height at which the HT measurements were performed. Micro-CT at 16 weeks for PEG (e), PEG-RGD (f), CM (g), empty control (h). PEG, synthetic particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD, synthetic particulated bone substitute material mixed a synthetic PEG hydrogel supplemented with RGD; CM, synthetic particulated bone substitute material covered with a non-cross-linked native collagen membrane. Micro-CT measurements of buccal and lingual first bone-to-implant contact (fBIC_CT) are shown in blue. Horizontal thickness measurements (red) at the buccal implant shoulder (HT_0) and at 2 mm (HT_2), respectively, 4 mm (HT_4) below the implant shoulder. Green measurements determine the height at which the (HT) measurements were performed. -percentage of regenerated area within total defect area (%; AA/TAA) (Fig. 3a) -the percentage of regenerated bone, bone substitute material, and non-mineralized tissue within the augmented area (%) (Fig. 3a) -first bone-to-implant contact (fBIC), measured from the implant shoulder to the first bone-to-implant contact on the buccal (fBIC_b) and lingual (fBIC_l) side (Fig. 3b) For TAA and AA, the following volumes were excluded:
-any augmented volume directly superior or lingual to the implant in its axial plane -any augmented volume inferior to the buccal extension of the inferior border of the defect -any augmented volume on either side of the defect in its mesio-distal aspect
Statistical analysis
Descriptive statistics included mean and standard deviation for the marginal bone levels, as well as median with minimum and maximum. These numbers are given for the two different time-points, as well as for the four different implant types separately. Multiple mixed models were fitted to the dependent variables for each time-point. In these four models, we adjusted for the potentially confounding factors individual dog (as random effect), treatment, side (right or left), and position of implant. Because of the small sample size, one could not investigate complex models with many factors and interaction terms. No correction for the multiple testing of the many dependent variables is applied because of the small study. As primary endpoint, we considered the variable % AA/TAA. The level of significance was set at P < 0.05.
Results
Clinical findings
All dogs were healthy during the entire study period, and neither systemic nor local adverse events were observed, and all implants were osseointegrated.
Histomorphometric analysis
The histomorphometric measurements were presented in Tables 1 and 2 . At 8 weeks, the median AA/TAA values were greater for groups with bone augmentation (PEG, PEG-RGD, and CM) ranging between 43.3% for CM (min 14.5%, max 72.0%) and 53.9% for PEG (min 31.0%, max 68.2%) compared to the empty control group with 22.9% (min 0.1%, max 48.2%) (Fig. 4) . Between 8 and 16 weeks, the AA/TAA ratio decreased in all groups. At 16 weeks, the median AA/ TAA ratios were between 31.2% for PEG-RGD (min 20.0%, max 50.0%) and 42.8% for CM (min 21.6%, max 51.2%) for groups with bone augmentation and 1.1% (min 0.0%, max 8.1%) for empty controls (Fig. 5) . The treatment effects were not statistically significant (P = 0.280) at 8 weeks, and significant (P < 0.0001) at 16 weeks. At 16 weeks, also, the site had a significant (P < 0.0001) impact, but the difference of AA/TAA at the two sites anterior (P4) and posterior (M1) is only about 2%. The median amount of newly formed bone was greatest in group CM 15.8% (min 6.8%, max 24.1%), lower in the two PEG groups (6.7% (min 2.1%, max 10.9%) for PEG and 6.3% (min 3.6%, max 20.2%) for PEG-RGD) at 8 weeks. Empty control sites rendered a median amount of new bone formation of 7.0% (min 0.7%, max 17.6%). No statistically significant differences were observed between the 4 groups by the mixed linear model (P = 0.108). At 16 weeks, the median values were highest for group CM at 17.7% (min 11.0%, max 20.6%), whereas in the two PEG groups, the amount of bone was 7.6% (min 3.9%, max 22.3%) for PEG and 9.7% (min 3.5%, max 25.5%) for PEG-RGD, respectively. Empty control sites rendered only a minimal amount of new bone formation with 1.3% (min 0.0, max 8.3%). Statistically significantly less bone formation was observed in group empty compared to all other groups (P < 0.001, 0.018 and 0.026). In addition, the difference between group CM and PEG was statistically significant (P = 0.0388).
All groups with bone augmentation (PEG, PEG-RGD, and CM) kept the amount of bone substitute material to a similar percentage ranging between 11.3% (min 0.0%, max 32.8%) for group CM and 18.0% (min 7.8%, max 32.2%) for PEG-RGD at 8 weeks. These numbers decreased slightly to 16 weeks with group CM demonstrating the least amount of bone substitute material (11.2%, min 8.0%, max 20.6%). None of the comparisons revealed statistically significant differences between the groups (P = 0.5203 at 8 weeks and P = 0.7378 at 16 weeks).
At both sacrifice time-points, the fBIC values were smaller on the lingual side compared to the buccal side. The respective median values on the buccal side ranged between 2.1 mm (min 0.7 mm, max 4.4 mm) (CM) and 3.7 mm (min 1.3 mm, max 5.2 mm) (PEG-RGD). Group CM was statistically significantly superior to all other groups at 8 weeks (P = 0.002, 0.004, and 0.026). At 16 weeks, the median values ranged between 2.5 mm (min 0.0 mm, max 3.8 mm) (PEG) and 3.8 mm (min 1.4 mm, max 4.8 mm) (empty) at 16 weeks. PEG and CM were statistically significantly superior compared to empty controls (P = 0.005 and <0.001).
Micro-CT analysis
The values measured in micro-CT were presented in Tables 3 and 4 . Similar to the histological measurements, the fBIC_CT values were smaller on the lingual compared to the buccal side (Fig. 2) . The median values on the buccal side ranged between 2.0 mm (min 0.9 mm, max 3.5 mm) (CM) and 3.2 mm (min 2.2 mm, max 3.8 mm) (PEG-RGD). Similar to the histological measurements, the fBIC_CT values decreased up to 16 weeks for all groups with bone augmentation (PEG, PEG-RGD, and CM) and ranged between 1.0 mm (min 0.5 mm, max 4.0 mm) (CM) and 3.5 mm (min 1 mm, max 4.4 mm) (empty) at 16 weeks. These differences were not significant at the two time-points (P = 0.547 and 0.104). The medians of the bucco-oral horizontal thickness of the mineralized tissue at the level of the implant shoulder (HT_0) were 0.00 for all groups, revealing no bone formation up to the implant shoulder at both time-points. At the level 2 mm below the implant shoulder (HT_2), median values ranged between 0.2 mm (min 0.0 mm, max 0.6 mm) (empty) and 1.8 mm (min 0.0 mm, max 2.2 mm) (PEG) at 8 weeks, which were significantly different (P = 0.044). Group PEG rendered statistically significantly higher values compared to empty and CM P = 0.012 and 0.033). In addition, PEG-RGD was statistically significantly superior compared to empty (P = 0.036). The median values decreased in all groups up to 16 weeks, except for group CM (from 0.3 mm (min 0.0 mm, max 1.4 mm) to 0.8 mm (min 0.0 mm, max 1.3 mm). There were no significant differences at 4 mm below the implant shoulder (HT_4) between the groups (P = 0.526), but significant not relevant differences at 8 weeks (P = 0.004).
Other than mentioned, none of the differences between the four groups were statistically significant (P > 0.05).
Discussion
The present preclinical study revealed, based on histomorphometric and micro-CT analyses, that bone can be partially regenerated at peri-implant dehiscence defects using a synthetic bone substitute material in combination with a PEG hydrogel matrix without a barrier membrane or a collagen membrane without significant differences between these groups for most outcome measures. The study also demonstrated that in terms of (i) the relative augmented area (%AA/TAA), the greatest regeneration can be expected at 8 weeks for all groups compared to 16 weeks; (ii) PEG hydrogel groups rendered roughly 50% of newly formed bone with values between 6.3% and 9.7% compared to 15.8% to 17.7% in the CM group; (iii) the first bone-to-implant contact, none of the groups regenerated bone up to the implant shoulder neither at 8 nor at 16 weeks, CM sites, however, were superior compared to all other groups.
Guided bone regeneration at buccal dehiscence defects is considered to be a successful treatment modality to regenerate bone along the implant surfaces as documented by preclinical and clinical studies using various combinations of materials (Hammerle et al. 2002) . In the present study, the relative augmented area (%AA/TAA) peaked at 8 weeks with values around 50% and then decreased up to 16 weeks, predominantly in the PEG hydrogel groups. In contrast to PEG, synthetic particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD, synthetic particulated bone substitute material mixed a synthetic PEG hydrogel supplemented with RGD; CM, synthetic particulated bone substitute material covered with a non-cross-linked native collagen membrane; empty, no further guided bone regeneration procedure; AA/TAA, % of regenerated area within total defect area; NB, newly formed bone; RBS, remaining bone substitute; fBIC, first bone to implant contact; B, buccal; L, lingual; SD, standard deviation. PEG, synthetic particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD, synthetic particulated bone substitute material mixed a synthetic PEG hydrogel supplemented with RGD; CM, synthetic particulated bone substitute material covered with a non-cross-linked native collagen membrane; empty, no further GBR procedure; AA/TAA, % of regenerated area within total defect area; NB, newly formed bone; RBS, remaining bone substitute; fBIC, first bone to implant contact; B, buccal; L, lingual; SD, standard deviation.
e80 | Clin. Oral Impl. Res. 28, 2017 / e76-e83 other studies with a similar critical size defect and comparable measuring techniques, relatively low values were obtained for all groups with bone augmentation (Thoma et al. 2012; Jung et al. 2014; Lee et al. 2016) . The amount of bone that can be regenerated depends on the surgical technique, the membrane and the membranesupporting bone or bone substitute material used. Empty controls unexpectedly showed new bone formation at 8 weeks, which disappeared again up to 16 weeks. Acute periimplant defects were used in the present study. These sites have demonstrated to be relatively reactive and might explain bone formation in empty controls at the earlier time-point. Between 8 and 16 weeks, remodeling processes were initiated and some of the newly formed bone might have been lost due to these processes. This also indicates that bone formation at periimplant defects undergoes structural changes during a longer time period. All groups with bone augmentation showed bone formation within the total defect area without statistically significant differences between the groups. However, the collagen membrane group revealed 50% more newly formed bone compared to the PEG groups. PEG hydrogel used in the present study appeared to be degraded rather fast with a negative impact on new bone formation. This is in line with previous preclinical studies using this type of PEG hydrogel with a low network density in different settings (Thoma et al. 2011) . In contrast to the classic GBR principle using a membrane, which keeps cells of faster growing adjacent tissues away from migrating into the augmented area, the combination of a bone substitute and a PEG hydrogel matrix follows a different concept (Hanseler et al. 2012; Jung et al. 2014 ). The clinical handling of such a putty material (PEG hydrogel plus bone substitute material) is relatively easy and clinically results in a stable augmented area. Histological analyses, however, demonstrated that this initially and clinically achieved stability did not persist and bone formation eventually was limited compared to control sites with a collagen membrane.
Ideally, bone regeneration at buccal dehiscence defects aims to regenerate bone up to the implant shoulder. Even though the vertical position of the implants was correct and a submerged healing mode was performed, none of the treatment modalities reached this goal. These results are in line with other studies using the same treatment modality (Lee et al. 2016; Pereira et al. 2015) . One of the explanations could be that bone substitute materials were displaced. In an in vitro study, the displacement of GBR materials was evaluated following wound closure and suturing. The collagen membrane collapses in the coronal portion of the augmented site as long as it is not fixated with pins or a block of bone substitute is used instead of granules (Mir-Mari et al. 2016) . Interestingly, a potentially negative impact of implant surfaces exposed to soft tissues could not be demonstrated. In two clinical studies employing immediate implants with simultaneous GBR, long-term outcomes based on clinical data and CBCT analyses demonstrated stable soft tissues, even though 35% and 25% of the implants had no buccal bone plate based on CBCTs (Benic et al. 2012; Kuchler et al. 2016) . The relatively high fBIC values were also reflected by the measurements for the horizontal thickness. The influence of GBR procedures was predominantly visible at a level 2 mm below the implant shoulder, whereas no bone regenerated more coronally, up to the implant shoulder. The horizontal thickness 4 mm below the bone crest was defined by the native ridge contour as this was the apical border of the original peri-implant defect. PEG hydrogels reached higher values at a level 2 mm below the implant shoulder at 8 weeks, but were undergoing greater remodeling process up to 16 weeks compared to the collagen membrane group. Various studies assessed the horizontal thickness following GBR procedures at buccal periimplant dehiscence defects over time ) (Zitzmann et al. 1997; Jung et al. 2009a,b) . All data are based on clinical measurements and demonstrate a decrease of the augmented area of approximately 1 mm over the course of 6 months.
These clinical data also demonstrate that, during the healing phase, augmented bone/ bone substitute materials are remodeled and that the horizontal thickness of the bone thereby decreases.
Previous experimental studies showed early bone formation when RGD was applied on implant surfaces (Germanier et al. 2006) and improved bone formation as well as more intimate contact to soft tissues when applied in combination with PEG hydrogels (Schneider et al. 2011; Thoma et al. 2011) . The amount of newly formed bone in the present study was higher with the addition of RGD, but did not reach statistically significant differences. The same applies for all other outcomes measures that were not significantly affected by RGD. Most of the positive effects of RGD found in other studies were measured at earlier time-points. Therefore, the influence of RGD might not be measurable at later follow-up time-points such as 8 or 16 weeks like in the present study.
Comparing both PEG groups with the collagen membrane in terms of guided bone regeneration, few differences were observed. In brief, CM showed better results in terms of the first bone-to-implant contact and more bone formation at the later time-point. The PEG formulation with a low density might be suitable as a matrix for bone substitute materials and demonstrated a good clinical applicability and stability of the augmented area prior to wound closure. The relatively fast degradation as reported in previous studies, might, however, have a negative impact on new bone formation and long-term space maintenance (Thoma et al. 2011) .
Bone can be regenerated partially at periimplant buccal dehiscence defects in dogs using a combination of a synthetic bone substitute and a collagen membrane or a PEG hydrogel matrix. Minimal differences were observed between the groups with bone augmentation for the most outcome measures. The CM group, however, demonstrated to be superior in terms of regenerated bone and the first bone-to-implant contact. The use of a PEG hydrogel with or without RGD, applied as a matrix mixed with a synthetic bone substitute material, might lack a sufficient stability over time for this kind of peri-implant defect.
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